88
Views
4
CrossRef citations to date
0
Altmetric
Original Research

High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso

, , , , , , , , , , , , & show all
Pages 371-380 | Published online: 28 Feb 2019

References

  • World Health OrganizationMalaria control improves for vulnerable in Africa, but global progress off-trackGenevaWHO2016 Available from: http://www.who.int/mediacentre/news/releases/2016/malaria-control-africa/en/Accessed September 28, 2017
  • World Health OrganizationWorld Malaria Report 2018GenevaWHO2018 Available from: http://apps.who.int/iris/bitstream/10665/162441/1/9789241549127_eng.pdfAccessed September 16, 2018
  • World Health OrganizationGuidelines for The Treatment of MalariaGenevaWHO2015
  • LindbladeKAO’NeillDBMathangaDPKatunguJWilsonMLTreatment for clinical malaria is sought promptly during an epidemic in a highland region of UgandaTrop Med Int Health200051286587511169276
  • BairdJKEffectiveness of antimalarial drugsN Engl J Med2005352151565157715829537
  • World Health Organization[homepage on the Internet]. T3: Test. Treat. Track initiativeGenevaWHO2016 Available from: https://www.who.int/malaria/areas/test_treat_track/en/Accessed December 2, 2018
  • GuiguemdéTRGbaryAROuedraogoJBCurrent aspects of malarial chemoresistance of subjects autochthonous in the OCCGE countries (West Africa)Ann Soc Belg Med Trop1991713199207 French1958105
  • GuiguemdeTRAoubaAOuedraogoJBLamizanaLTen-year surveillance of drug-resistant malaria in Burkina Faso (1982–1991)Am J Trop Med Hyg19945066997048024062
  • Ministry of Health/National Malaria Control Program[National Guidelines for the Diagnosis, Treatment, and Prevention of Malaria in Burkina Faso] Directives Nationales pour La prise en charge Du paludisme Au Burkina FasoBurkina Faso2017 French
  • National Institute of Statistic and Demography and ICF International[Demographic and Health and Multiple Indicator Cluster Survey (DHSBF-MICS IV)] Enquête Démographique et de Santé et Indicateurs Multiples (EDSBF-MICS IV) 2010Calverton, Maryland2012 French
  • KoulidiatiJLDe AllegriMSouaresAFactors associated with effective coverage of child health services in Burkina FasoTrop Med Int Health201823111188119930117640
  • SIG: Service d’Information du Gouvernement – Burkina FasoCompte rendu du Conseil des ministres du mercredi 02 mars 2016 Available from: http://www.sig.bf/2016/03/compte-rendu-du-conseil-des-ministres-du-mercredi-02-mars-2016/Accessed November 24, 2018
  • RiddeVNitièmaAPDadjoariMImprove the accessibility of essential drugs for the populations of one medical region in Burkina FasoSante2005153175182 French16207580
  • Ministry of Health/Directorate General of Studies and Sectoral StatisticsStatistical Yearbook 2017Burkina Faso2018
  • Ministry of Health/Directorate General of Studies and Sectoral StatisticsStatistical Yearbook 2016Burkina Faso2017 French
  • National Malaria Control Program and US President’s Malaria InitiativeMalaria Operational Plan Fiscal Year (FY) 2017NMCP and U.S. Global Malaria CoordinatorBurkina Faso2016
  • WhiteNJPongtavornpinyoWMaudeRJHyperparasitaemia and low dosing are an important source of anti-malarial drug resistanceMalar J20098125319906307
  • World Health OrganizationGlobal report on antimalarial efficacy and drug resistance: 2000–2010GenevaWHO2017 Available from: https://www.who.int/malaria/publications/atoz/9789241500470/en/Accessed August 22, 2018
  • NzilaAOkomboJOhumaEAl-ThukairAUpdate on the in vivo tolerance and in vitro reduced susceptibility to the antimalarial lumefantrineJ Antimicrob Chemother201267102309231522761327
  • AdjuikMBabikerAGarnerPArtesunate combinations for treatment of malaria: meta-analysisLancet2004363940291714723987
  • AmponsahAOPatient related factors affecting adherence to antimalarial medication in an urban estate in GhanaMalar Res Treat2015201545253925767736
  • LawfordHZurovacDO’ReillyLAdherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, KenyaMalar J201110128121943224
  • OnyangoEOAyodoGWatsierahCAFactors associated with non-adherence to artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of Western KenyaBMC Infect Dis201212114322726955
  • MaceKEMwandamaDJafaliJAdherence to treatment with artemether-lumefantrine for uncomplicated malaria in rural MalawiClin Infect Dis201153877277921921220
  • CohenJLYavuzEMorrisAArkedisJSabotODo patients adhere to over-the-counter artemisinin combination therapy for malaria? Evidence from an intervention study in UgandaMalar J20121118322443291
  • BarnesKIDurrheimDNLittleFEffect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South AfricaPLoS Med2005211e33016187798
  • DondorpAMNostenFYiPArtemisinin resistance in Plasmodium falciparum malariaN Engl J Med2009361545546719641202
  • AshleyEADhordaMFairhurstRMSpread of artemisinin resistance in Plasmodium falciparum malariaN Engl J Med2014371541142325075834
  • LuFCulletonRZhangMEmergence of indigenous artemisinin-resistant Plasmodium falciparum in AfricaN Engl J Med20173761099199328225668
  • BanekKLalaniMStaedkeSGChandramohanDAdherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidenceMalar J2014131724386988
  • DerraKRouambaEKaziengaAProfile: Nanoro health and demographic surveillance systemInt J Epidemiol20124151293130123045201
  • World Health OrganizationThe World Health Report 2006 – Chapter 1. Health workers: a global profileGenevaWHO2006 Available from: http://www.who.int/whr/2006/06_chap1_en.pdfAccessed December 02, 2018
  • BrownMTBussellJKMedication adherence: who cares?Mayo Clin Proc201186430431421389250
  • FarmerKCMethods for measuring and monitoring medication regimen adherence in clinical trials and clinical practiceClin Ther19992161074109010440628
  • BrunetteWSundtMDellNOpen data kit 2.0: Expanding and refining information services for developing regionsIn Proceedings of the 14th Workshop on Mobile Computing Systems and ApplicationsFebruary 26–27, 2013Jekyll Island, GA Article 10
  • RajaATridaneAGaffarALindquistTPribadiKAndroid and ODK based data collection framework to aid in epidemiological analysisOnline J Public Health Inform20145322824678381
  • Institut national de la statistique & et de la démographie (INSD)Rapport Enquête multisectorielle continue (EMC) 2014 Profil de pauvreté et d’inégalités2015
  • AjayiIOBrowneENGarshongBFeasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sitesMalar J200871618182114
  • RatsimbasoaARavonyHVonimpaisomihantaJACompliance, safety, and effectiveness of fixed-dose artesunate-amodiaquine for presumptive treatment of non-severe malaria in the context of home management of malaria in MadagascarAm J Trop Med Hyg201286220321022302849
  • SimbaDOKakokoDTomsonGAdherence to artemether/lumefantrine treatment in children under real-life situations in rural TanzaniaTrans R Soc Trop Med Hyg201210613922099005
  • OgollaJOAyayaSOOtienoCALevels of adherence to coartem© in the routine treatment of uncomplicated malaria in children aged below five years, in KenyaIran J Public Health2013422129133
  • FitchettJREthical considerations of clinical trials in the developing worldTrans R Soc Trop Med Hyg2009103875676019345967
  • TintoHValeaISorghoHThe impact of clinical research activities on communities in rural Africa: the development of the clinical research unit of Nanoro (CRUN) in Burkina FasoMalar J201413111324655351
  • PREGACT Study GroupPekyiDAmpromfiAAFour artemisinin-based treatments in African pregnant women with malariaN Engl J Med20163741091392726962727
  • SirimaSBTionoABGansanéAThe efficacy and safety of a new Fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparumMalar J2009814819291301
  • TagborHBruceJBrowneERandalAGreenwoodBChandramohanDEfficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trialLancet200636895441349135617046467
  • SchrammBValehPBaudinETolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, LiberiaMalar J201312125023866736
  • World Health Organization WHOPolicy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum Malaria control in Highly Seasonal Transmission Areas of the Sahel Sub-region in AfricaGenevaWHO2015 Available from: http://www.who.int/malaria/publications/atoz/who_smc_policy_recommendation/en/Accessed May 23, 2018
  • World Health Organization [homepage on the Internet]New WHO guidelines to promote proper use of alternative medicinesGenevaWHO2010 Available from: http://www.who.int/mediacentre/news/releases/2004/pr44/en/Accessed December 3, 2018
  • KravitzRLMelnikowJMedical adherence research: time for a change in direction?Med Care200442319719915076818